Načítá se...
Antimetabolite Treatment for Pancreatic Cancer
Pancreatic cancer is a deadly and aggressive disease. Less than 1% of diagnosed patients survive 5 years with an average survival time of only 4–8 months. The only option for metastatic pancreatic cancer is chemotherapy where only the antimetabolites gemcitabine and 5-fluorouracil are used clinicall...
Uloženo v:
| Vydáno v: | Chemotherapy (Los Angel) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494102/ https://ncbi.nlm.nih.gov/pubmed/26161298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2167-7700.1000137 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|